Investigating recent advances in pharmacotherapy for acute and chronic ocular pain post-cataract surgery.
作者信息
Donthineni Pragnya R, Munger Wade, Galor Anat
机构信息
Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA.
Shantilal Shanghvi Cornea Institute, L.V Prasad Eye Institute, Hyderabad, India.
出版信息
Expert Opin Pharmacother. 2024 Nov;25(16):2107-2113. doi: 10.1080/14656566.2024.2421323. Epub 2024 Oct 28.
Abstract
摘要
相似文献
1
Investigating recent advances in pharmacotherapy for acute and chronic ocular pain post-cataract surgery.探究白内障手术后急慢性眼痛药物治疗的最新进展。
Expert Opin Pharmacother. 2024 Nov;25(16):2107-2113. doi: 10.1080/14656566.2024.2421323. Epub 2024 Oct 28.
2
Efficacy and safety of bromfenac 0.075% formulated in DuraSite for pain and inflammation in cataract surgery.在白内障手术中，DuraSite 配方的 0.075%溴芬酸的疗效和安全性与疼痛和炎症。
Expert Opin Pharmacother. 2019 Oct;20(14):1703-1709. doi: 10.1080/14656566.2019.1645834. Epub 2019 Jul 25.
3
To Study the Efficacy of Difluprednate Ophthalmic Emulsion and Prednisolone Acetate Ophthalmic Suspension on Post-operative Inflammation in Cataract Surgery.研究地氟泼尼龙眼膏和醋酸泼尼松龙滴眼液对白内障手术后炎症的疗效。
J Clin Diagn Res. 2016 Dec;10(12):NC05-NC08. doi: 10.7860/JCDR/2016/21690.9035. Epub 2016 Dec 1.
4
Loteprednol Etabonate (Submicron) Ophthalmic Gel 0.38%: A Review in Post-Operative Inflammation and Pain Following Ocular Surgery.Loteprednol 乙二酸酯（亚微米）眼用凝胶 0.38%：用于眼部手术后炎症和疼痛的综述。
Clin Drug Investig. 2020 Apr;40(4):387-394. doi: 10.1007/s40261-020-00899-2.
5
Nepafenac dosing frequency for ocular pain and inflammation associated with cataract surgery.用于白内障手术相关眼痛和炎症的奈帕芬胺给药频率。
J Ocul Pharmacol Ther. 2008 Dec;24(6):593-9. doi: 10.1089/jop.2008.0023.
6
Loteprednol etabonate ophthalmic gel 0.5%: a review of its use in post-operative inflammation and pain following ocular surgery.卤替泼诺眼部凝胶 0.5%：在眼部手术后炎症和疼痛中的应用评价。
Drugs. 2013 Jun;73(9):949-58. doi: 10.1007/s40265-013-0073-8.
7
Color of intra-ocular lens and cataract type are prognostic determinants of health indices after visual and photoreceptive restoration by surgery.人工晶状体的颜色和白内障类型是手术恢复视力和光感受功能后健康指标的预后决定因素。
Rejuvenation Res. 2015 Apr;18(2):145-52. doi: 10.1089/rej.2014.1613. Epub 2015 Apr 9.
8
Telephone follow-up one day post-cataract surgery.白内障手术后一天电话随访。
Clin Exp Optom. 2023 Sep;106(7):741-745. doi: 10.1080/08164622.2022.2146482. Epub 2022 Dec 4.
9
Beneficial effects of small-incision cataract surgery in patients demonstrating reduced ocular blood flow characteristics.小切口白内障手术对眼部血流特征降低的患者的有益效果。
Eye (Lond). 2005 Jun;19(6):670-5. doi: 10.1038/sj.eye.6701620.
10
Neuropathic ocular surface pain: Emerging drug targets and therapeutic implications.神经病理性眼表疼痛：新兴的药物靶点和治疗意义。
Expert Opin Ther Targets. 2022 Aug;26(8):681-695. doi: 10.1080/14728222.2022.2122438. Epub 2022 Sep 20.
本文引用的文献
1
The role of topical insulin in ocular surface restoration: A review.局部胰岛素在眼表面修复中的作用：综述。
Surv Ophthalmol. 2024 Sep-Oct;69(5):805-817. doi: 10.1016/j.survophthal.2024.04.003. Epub 2024 Apr 10.
2
A bibliometric and visualized analysis of the pathogenesis of cataracts from 1999 to 2023.1999年至2023年白内障发病机制的文献计量学与可视化分析
Heliyon. 2024 Feb 13;10(4):e26044. doi: 10.1016/j.heliyon.2024.e26044. eCollection 2024 Feb 29.
3
Anti-inflammatory medication use after cataract surgery: online survey of practice patterns.白内障手术后抗炎药物的使用：实践模式的在线调查。
J Cataract Refract Surg. 2024 Mar 1;50(3):224-229. doi: 10.1097/j.jcrs.0000000000001341.
4
Overview of Recent Advances in Nano-Based Ocular Drug Delivery.基于纳米的眼部药物输送的最新进展概述。
Int J Mol Sci. 2023 Oct 19;24(20):15352. doi: 10.3390/ijms242015352.
5
Postoperative Complications of True Dropless Cataract Surgery versus Standard Topical Drops.无滴剂真性白内障手术与标准局部滴药法的术后并发症
J Acad Ophthalmol (2017). 2023 Jul 28;15(2):e144-e153. doi: 10.1055/s-0043-1771043. eCollection 2023 Jul.
6
0.2% Betamethasone Sodium Phosphate: A Multicenter, Randomized, Double-Masked Study to Compare Its Ocular Safety, Tolerability, and Efficacy to Vehicle in Cataract Surgery Subjects.0.2%倍他米松磷酸钠：一项多中心、随机、双盲研究，比较其在白内障手术患者中与赋形剂相比的眼部安全性、耐受性和疗效。
Clin Ophthalmol. 2023 Aug 5;17:2219-2230. doi: 10.2147/OPTH.S419857. eCollection 2023.
7
Management of cataract in dry eye disease: Preferred practice pattern guidelines.干眼病性白内障的管理：优先实践模式指南。
Indian J Ophthalmol. 2023 Apr;71(4):1364-1372. doi: 10.4103/IJO.IJO_2807_22.
8
Topical Ocular TRPV1 Antagonist SAF312 (Libvatrep) for Postoperative Pain After Photorefractive Keratectomy.局部眼部 TRPV1 拮抗剂 SAF312（利伐曲普坦）治疗屈光性角膜切削术后疼痛。
Transl Vis Sci Technol. 2023 Mar 1;12(3):7. doi: 10.1167/tvst.12.3.7.
9
Novel Treatments for Chronic Ocular Surface Pain.慢性眼表疼痛的新疗法。
Cornea. 2023 Mar 1;42(3):261-271. doi: 10.1097/ICO.0000000000003193. Epub 2022 Dec 19.
10
OCS-01 (Novel Topical Dexamethasone Formulation) in Inflammation and Pain Post Cataract Surgery: A Randomized, Double-Masked, Vehicle-Controlled Study.OCS-01（新型局部用皮质类固醇制剂）在白内障手术后炎症和疼痛中的应用：一项随机、双盲、对照研究。
Clin Ther. 2022 Dec;44(12):1577-1587. doi: 10.1016/j.clinthera.2022.11.003. Epub 2022 Dec 8.
Zotero 插件